(Q40659575)

22 September 2017

New homologous bioassays for human lactogens show that agonism or antagonism of various analogs is a function of assay sensitivity (English)

1 reference

22 September 2017

Sophie Bernichtein

1

1 reference

22 September 2017

Sébastien Jeay

2

1 reference

22 September 2017

Roland Vaudry

3

1 reference

22 September 2017

Paul A Kelly

4

1 reference

22 September 2017

Vincent Goffin

5

1 reference

22 September 2017

1 February 2003

1 reference

22 September 2017

1 reference

22 September 2017

20

1 reference

22 September 2017

1-2

1 reference

22 September 2017

177-190

1 reference

https://scigraph.springernature.com/pub.10.1385/endo:20:1-2:177

22 September 2017

0 references

cites work

Rational design of potent antagonists to the human growth hormone receptor

1 reference

12 December 2020

A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription

1 reference

12 December 2020

Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11.

1 reference

12 December 2020

A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum

1 reference

12 December 2020

Cytokine receptor signalling through two novel families of transducer molecules: Janus kinases, and signal transducers and activators of transcription

1 reference

12 December 2020

Prolactin receptor signal transduction in cells of the immune system.

1 reference

12 December 2020

Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse

1 reference

12 December 2020

In vivo studies of the anti-tumor effects of a human prolactin antagonist, hPRL-G129R.

1 reference

12 December 2020

Bacterial production and purification of recombinant human prolactin

1 reference

12 December 2020

In vitro and in vivo studies of antagonistic effects of human growth hormone analogs.

1 reference

12 December 2020

The human growth hormone antagonist B2036 does not interact with the prolactin receptor

1 reference

12 December 2020

A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor

1 reference

12 December 2020

Receptor dimerization determines the effects of growth hormone in primary rat adipocytes and cultured human IM-9 lymphocytes

1 reference

12 December 2020

Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay

1 reference

12 December 2020

Receptor-mediated mitogenic action of prolactin in a rat lymphoma cell line

1 reference

12 December 2020

Alanine-scanning mutagenesis of human prolactin: importance of the 58-74 region for bioactivity

1 reference

12 December 2020

S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist

1 reference

12 December 2020

Prolactin as a mitogen in mammary cells

1 reference

12 December 2020

Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells

1 reference

12 December 2020

Growth hormone prevents apoptosis through activation of nuclear factor-kappaB in interleukin-3-dependent Ba/F3 cell line

1 reference

12 December 2020

Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormone.

1 reference

12 December 2020

Mechanism of ruminant placental lactogen action: molecular and in vivo studies

1 reference

12 December 2020

The Nb2 form of prolactin receptor is able to activate a milk protein gene promoter

1 reference

12 December 2020

G120R, a human growth hormone antagonist, shows zinc-dependent agonist and antagonist activity on Nb2 cells

1 reference

12 December 2020

Pseudophosphorylated prolactin (S179D PRL) inhibits growth and promotes beta-casein gene expression in the rat mammary gland

1 reference

12 December 2020

Mechanism-based design of prolactin receptor antagonists.

1 reference

12 December 2020

Studies on the microheterogeneity and in vitro activity of glycosylated and nonglycosylated recombinant human prolactin separated using a novel purification process

1 reference

12 December 2020

Biological properties of human prolactin analogs depend not only on global hormone affinity, but also on the relative affinities of both receptor binding sites

1 reference

12 December 2020

Characterization of a novel and functional human prolactin receptor isoform (deltaS1PRLr) containing only one extracellular fibronectin-like domain

1 reference

12 December 2020

Inhibition of lactogenic activities of ovine prolactin and human growth hormone (hGH) by a novel form of a modified recombinant hGH.

1 reference

12 December 2020

Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals

1 reference

12 December 2020

Expression of two forms of prolactin receptor in rat ovary and liver

1 reference

12 December 2020

Bioactive recombinant methionyl bovine prolactin: structure-function studies using site-specific mutagenesis

1 reference

12 December 2020

Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines

1 reference

12 December 2020

T47DCO cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancers to hormone resistance.

1 reference

12 December 2020

Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation

1 reference

12 December 2020

Identifiers

DOI

10.1385/ENDO:20:1-2:177

1 reference

Dimensions Publication ID

22 September 2017

0 references

1 reference